http://purl.org/np/RA6kybT0bF3H49VODbyQiGKu0wv73nDJDrttunfHrEjVU
.trig | .trig.txt | .jelly | .jelly.txt
@prefix biolink: <https://w3id.org/biolink/vocab/> . @prefix ns1: <https://w3id.org/np/o/ntemplate/> . @prefix this: <http://purl.org/np/RA6kybT0bF3H49VODbyQiGKu0wv73nDJDrttunfHrEjVU> . @prefix sub: <http://purl.org/np/RA6kybT0bF3H49VODbyQiGKu0wv73nDJDrttunfHrEjVU#> . @prefix schema: <https://schema.org/> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix dct: <http://purl.org/dc/terms/> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix orcid: <https://orcid.org/> . @prefix prov: <http://www.w3.org/ns/prov#> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo . } sub:assertion { <http://purl.obolibrary.org/obo/DOID_10763> biolink:category biolink:Disease . sub:association a rdf:Statement; rdf:object <http://purl.obolibrary.org/obo/DOID_10763>; rdf:predicate biolink:treats; rdf:subject <https://identifiers.org/drugbank:DB00012>; rdfs:label "\"Aranesp is contraindicated in patients with: Uncontrolled hypertension [see Warnings and Precautions ( 5.3 )] Pure red cell aplasia (PRCA) that begins after treatment with Aranesp or other erythropoietin protein drugs [see Warnings and Precautions ( 5.6 )] Serious allergic reactions to Aranesp [see Warnings and Precautions ( 5.7 )] Uncontrolled hypertension ( 4 Pure red cell aplasia (PRCA) that begins after treatment with Aranesp or other erythropoietin protein drugs ( 4 Serious allergic reactions to Aranesp ( 4\""; biolink:provided_by <https://w3id.org/um/NeuroDKG>; biolink:relation schema:MedicalContraindication . <https://identifiers.org/drugbank:DB00012> biolink:category biolink:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "QSvUuZJa+RTcbSkP/zgsd3/RYRri+CXFLx4fnUtwo1so825xMCdnhT2cT+Vk8o4RGgH9QiyUiC7u2bQ309iXdikM/YCrg7T+9w/G+/i/pmbuQN7t3rDLLumFs1YB27QotZjb1uawtXazMDlm3glJQ0NowB/l+MALSDIOIKE2CDo="; npx:hasSignatureTarget this: . this: dct:created "2021-08-23T17:56:07.507+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; ns1:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>; ns1:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>; ns1:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> . }